Medical biotechnology developer, manufacturer and marketer of differentiated therapies and services for hospital intensive and critical care settings. Product portfolio includes plasma proteins, biosimilars, later‑generation oncology drugs, and programs in clinical research, molecular and regenerative medicine, gene therapy, peptides and oligonucleotides.